{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:05:22Z","timestamp":1782925522620,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd009034","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000}}],"reference-count":132,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009034.pub2","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T11:10:13Z","timestamp":1467198613000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Sequential versus standard triple first-line therapy for<i>Helicobacter pylori<\/i>eradication"],"prefix":"10.1002","volume":"2016","author":[{"given":"Olga P","family":"Nyssen","sequence":"first","affiliation":[{"name":"Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IIS-IP), and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Gastroenterology Unit; Madrid Madrid Spain 28006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian G","family":"McNicholl","sequence":"additional","affiliation":[{"name":"Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IIS-IP), and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Gastroenterology Unit; Madrid Madrid Spain 28006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Megraud","sequence":"additional","affiliation":[{"name":"H\u00f4pital Pellegrin; Bact\u00e9riologie-Enfants; Centre Hospitalier Universitaire de Bordeaux Place Amelia-Raba-Leon Bordeaux Cedex France 33076"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Savarino","sequence":"additional","affiliation":[{"name":"Universita di Genova; Dipartimento di Medicina Interna e Specialita Mediche; Viale Benedetto xv m6 Genova Italy 16132"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Oderda","sequence":"additional","affiliation":[{"name":"Universita del Piemonte Orientale; Paediatric Endoscopy Units; Via Solaroli 17 Novara Italy 28100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo A","family":"Fallone","sequence":"additional","affiliation":[{"name":"McGill University Health Centre; Faculty of Medicine; Royal Victoria Hospital 687 Pine Avenue West, Room R228 Montreal QC Canada H3A 1A1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Fischbach","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences; Department of Epidemiology; 4301 West Markham, # 820 Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Bazzoli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Bologna; Dipartimento di Scienze Mediche e Chirurgiche; Policlinico S.Orsola Via Massarenti 9, Via Borgo San Pietro 137 Bologna Italy I-40138"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IIS-IP), and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Gastroenterology Unit; Madrid Madrid Spain 28006"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2011.01.023","article-title":"Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial","volume":"159","author":"Albrecht","year":"2011","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0253-7613.117757","article-title":"Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children","volume":"45","author":"Ali Habib","year":"2013","journal-title":"Indian Journal of Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0003|cit3","first-page":"303","article-title":"A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy","volume":"31","author":"Aminian","year":"2010","journal-title":"Tropical Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0016-5085(13)60190-0","article-title":"A randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. Pylori infection","volume":"144","author":"Ang","year":"2013","journal-title":"Gastroenterology. Conference: Digestive Disease Week 2013, DDW 2013 Orlando, FL United States"},{"issue":"7","key":"10.1002\/14651858.CD009034.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/jgh.12892","article-title":"Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection","volume":"30","author":"Ang","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1155\/2013\/143047","article-title":"A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian north","volume":"27","author":"Morse","year":"2013","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"5 SUPPL. 1","key":"10.1002\/14651858.CD009034.pub2-BIB0007|cit7","first-page":"S104","article-title":"An update: a randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. Pylori infection in Singapore","volume":"146","author":"Song","year":"2014","journal-title":"Gastroenterology. Digestive Disease Week 2014, DDW 2014"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MPG.0b013e318229c769","article-title":"Sequential therapy vs. tailored triple therapies for Helicobacter pylori infection in children: A prospective, open-label, multi-center study","volume":"53","author":"Bontems","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"18\/19","key":"10.1002\/14651858.CD009034.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3748\/wjg.v18.i19.2377","article-title":"Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection","volume":"21","author":"Choi","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD009034.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1440-1746.2012.07249.x","article-title":"Ten-day sequential versus triple therapy for Helicobacter\u2009pylori eradication: a prospective, open-label, randomized trial","volume":"27","author":"Chung","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2036.2004.01818.x","article-title":"Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure","volume":"19","author":"Francesco","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.dld.2003.12.015","article-title":"The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study","volume":"36","author":"Francesco","year":"2004","journal-title":"Digestive & Liver Disease"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0013|cit13","first-page":"S","article-title":"Standard triple therapy for Helicobacter pylori is still the best first line treatment in Brazil, compared with sequential therapy: a randomized, prospective, double-blind, placebo-controlledStudy","volume":"146","author":"Eisig","year":"2014","journal-title":"Gastroenterology. Conference: Digestive Disease Week (DDW)"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1016\/S1590-8658(02)90065-4","article-title":"Helicobacter pylori eradication: one week triple therapy versus 10-day sequential regimen introduction","volume":"34","author":"Focareta","year":"2002","journal-title":"Digestive Liver Disease"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0015|cit15","first-page":"C091","article-title":"Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection?","volume":"33","author":"Focareta","year":"2003","journal-title":"Digestive and Liver Disease"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(11)60604-5","article-title":"High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection","volume":"140","author":"Franceschi","year":"2011","journal-title":"Gastroenterology"},{"issue":"34","key":"10.1002\/14651858.CD009034.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.3748\/wjg.v16.i34.4357","article-title":"Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication","volume":"16","author":"Gao","year":"2010","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/ajg.2009.555","article-title":"Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children","volume":"104","author":"Gatta","year":"2009","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0019|cit19","first-page":"S","article-title":"A randomized trial comparing 14-day triple, 10-day sequential, and 5-day concomitant therapy to eradicate Helicobacter pylori in seven Latin American populations","volume":"NA","author":"Ferreccio","year":"2011","journal-title":"AGA Abstracts"},{"issue":"9790","key":"10.1002\/14651858.CD009034.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD009034.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"5936-42","DOI":"10.1128\/AAC.02922-14","article-title":"Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-Day concomitant therapies for Helicobacter pylori infection","volume":"58","author":"Hsu","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD009034.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/apt.12516","article-title":"Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study","volume":"38","author":"Huang","year":"2013","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12664-013-0304-7","article-title":"Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial","volume":"32","author":"Javid","year":"2013","journal-title":"Indian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0024|cit24","first-page":"280","article-title":"Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea","volume":"51","author":"Choi","year":"2008","journal-title":"Taehan Sohwagi Hakhoe Chi [The Korean Journal of Gastroenterology]"},{"issue":"5 Suppl. 1","key":"10.1002\/14651858.CD009034.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.1016\/S0016-5085(13)62099-5","article-title":"Effectiveness of 10 day-sequential treatment for Helicobacter pylori eradication in Korea","volume":"144","author":"Jeon","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2036.2011.04843.x","article-title":"Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy forHelicobacter pylori in Korea","volume":"34","author":"Kim","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.clinre.2012.10.002","article-title":"Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study","volume":"37","author":"Lahbabi","year":"2013","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7196\/SAMJ.7012","article-title":"Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya","volume":"103","author":"Laving","year":"2013","journal-title":"South African Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD009034.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/00365521.2014.896409","article-title":"A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea","volume":"49","author":"Lee","year":"2014","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0030|cit30","unstructured":"Kim J Kim J Kim B Kim H Bang B Kim C Triple therapy, sequential therapy, and concomitant therapy for Helicobacter pylori infection in Korea: A multicenter, randomized controlled trial Helicobacter. 27th International Workshop on Helicobacter and Microbiota in Chronic Digestive Inflammation and Gastric Cancer Rome Italy 2014 80"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3748\/wjg.v21.i1.351","article-title":"Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies","volume":"21","author":"Lee","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0032|cit32","unstructured":"Lim KJ Kim JS Kim BW Kim CH Kim HG Bhang BW Triple therapy, sequential therapy, and concomitant therapy for Helicobacter pylori infection in Korea: A multicenter, randomized controlled trial Journal of Gastroenterology and Hepatology 2014 230"},{"issue":"9862","key":"10.1002\/14651858.CD009034.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cgh.2013.09.043","article-title":"Sequential therapy for 10 days versus triple therapy for 14 days in the first-line treatment of Helicobacter pylori infection- a multicenter, open-label, randomized trial","volume":"12","author":"Liou","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0016-5085(11)60606-9","article-title":"10-day and 14-day sequential therapy vs. standard triple therapy for Helicobacter pylori infection in a Puerto Rican treatment-naive population: an interim analysis","volume":"140","author":"Lopez-Rom\u00e1n","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0036|cit36","first-page":"988-90","article-title":"Comparison of the efficacy of 10-day sequential therapy and conventional triple therapy for Helicobacter pylori eradication in children","volume":"12","author":"Lu","year":"2010","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"10","key":"10.1002\/14651858.CD009034.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2036.2010.04274.x","article-title":"Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication","volume":"31","author":"Molina-Infante","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12664-013-0357-7","article-title":"Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study","volume":"32","author":"Nasa","year":"2013","journal-title":"Indian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1746.2011.06922.x","article-title":"Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: A prospective, randomized study","volume":"27","author":"Oh","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0040|cit40","first-page":"A","article-title":"Sequential regimens have greater efficacy and better tolerability than standard triple therapy in the eradication of Helicobacter pylori","volume":"M1065","author":"Paoluzi","year":"2008","journal-title":"Digestive Disease Week (AGA abstracts)"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MCG.0b013e3181acebef","article-title":"Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability","volume":"44","author":"Paoluzi","year":"2010","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0042|cit42","unstructured":"Kim S. Park H Jung M Huh J Jeon S Ten-day sequential therapy is a promising therapeutic approach for helicobacter pylori infection in naive patients: a randomized multicenter trial Helicobacter. 25th International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer: European Helicobacter Study Group Ljubljana Slovenia 2012 99 100"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2011.04902.x","article-title":"Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in na\u00efve patients","volume":"35","author":"Park","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0044|cit44","first-page":"A61","article-title":"Ten-day sequential therapy is a promising therapeutic approach for Helicobacter pylori infection in na\u00efve patients: a randomized multicenter trial","volume":"60 (Suppl 3)","author":"Park","year":"2011","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD009034.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/1751-2980.12171","article-title":"Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacterpylori infection: Patients\u2019 compliance and bacterial eradication rates","volume":"15","author":"Rakici","year":"2014","journal-title":"Journal of Digestive Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009034.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1155\/2006\/258768","article-title":"Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.","volume":"20","author":"Scaccianoce","year":"2006","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD009034.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00228-013-1524-6","article-title":"Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study","volume":"69","author":"Seddik","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0048|cit48","first-page":"73","article-title":"Sequential and quadruple therapies for Helicobacter Pylori eradication compared with triple therapy in Slovenia: a multicenter, prospective, randomized, controlled trial","volume":"17","author":"Tepes","year":"2012","journal-title":"Helicobacter"},{"issue":"8","key":"10.1002\/14651858.CD009034.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-146-8-200704170-00006","article-title":"Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial","volume":"146","author":"Vaira","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"29","key":"10.1002\/14651858.CD009034.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.11569\/wcjd.v19.i29.3100","article-title":"Sequential therapy versus standard triple therapy for Helicobacter pylori eradication","volume":"19","author":"Wu","year":"2011","journal-title":"World Chinese Journal of Digestology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0051|cit51","first-page":"77-143. Abtract","article-title":"Sequential therapy for helicobacter pylori eradication in adults compared with triple therapy in China: a multiple- centre, prospective, randomized, controlled trial","volume":"16","author":"Yan","year":"2011","journal-title":"Helicobacter"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ajg.2014.26","article-title":"A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial","volume":"109","author":"Zhou","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1590-8658(03)00081-1","article-title":"A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?","volume":"35","author":"Zullo","year":"2003","journal-title":"Digestive and Liver Disease"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1365-2036.2005.02519.x","article-title":"High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study","volume":"21","author":"Zullo","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1053\/j.gastro.2005.09.007","article-title":"Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial","volume":"129","author":"Francavilla","year":"2005","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD009034.pub2-BIB0056|cit56","first-page":"1693","article-title":"A 10-day sequential therapy for Helicobacter pylori-infected patients: an analysis of 39 cases","volume":"17","author":"Hu","year":"2009","journal-title":"Shi Jie Hua Ren Xiao Hua Za Zhi [World Chinese Journal of Digestology]"},{"issue":"8","key":"10.1002\/14651858.CD009034.pub2-BIB0057|cit57","first-page":"563","article-title":"A 10-day sequential therapy for eradication of Helicobacter pylori infection in children","volume":"50","author":"Huang","year":"2012","journal-title":"Zhonghua Er Ke za Zhi. [Chinese Journal of Pediatrics]"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1751-2980.2012.00575.x","article-title":"Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication","volume":"13","author":"Huang","year":"2012","journal-title":"Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0059|cit59","first-page":"392-479","article-title":"Sequential treatment regimens of H. pylori in patients with non-ulcer dyspepsia","volume":"13","author":"Kadayifci","year":"2008","journal-title":"Helicobacter"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0060|cit60","unstructured":"Kim JS Kim B Ji J Lee B Choi H Sequential versus triple therapy for the treatment of Helicobacter pylori: A nationwide study Helicobacter. 26th International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer of the European Helicobacter Study Group Madrid Spain 2013 83 4"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2036.2001.00929.x","article-title":"Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection","volume":"15","author":"Nagahara","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2036.1999.00493.x","article-title":"The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen","volume":"13","author":"Neville","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0063|cit63","first-page":"130","article-title":"Sequential versus classical triple treatment study in a Greek population","volume":"18","author":"Ntouli","year":"2013","journal-title":"Helicobacter"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0064|cit64","first-page":"A","article-title":"Helicobacter pylori eradication with either Conventional 10-day triple therapy or 10-day modified sequential regimen (preliminary report)","volume":"134","author":"Ruiz-Obald\u00eda","year":"2008","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD009034.pub2-BIB0065|cit65","first-page":"S115","article-title":"One-year effectiveness and costs of six alternative H. Pylori test\/treat and retest\/retreat strategies using triple, concomitant or sequential drug regimens in seven Latin American Sites (SWOG Trial S0701)","volume":"142","author":"Torres","year":"2012","journal-title":"Gastroenterology. Digestive Diease Week 2012, DDW 2012 San Diego, CA United States"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2011\/967671","article-title":"Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients","volume":"25","author":"Urgesi","year":"2011","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.clinthera.2008.03.009","article-title":"Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia","volume":"30","author":"Uygun","year":"2008","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD009034.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/00365521.2011.584894","article-title":"Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure","volume":"46","author":"Valooran","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"35","key":"10.1002\/14651858.CD009034.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.11569\/wcjd.v17.i35.3666","article-title":"Efficacy of tinidazole-containing sequential therapy in the eradication of Helicobacter pylori infection. [Chinese]","volume":"17","author":"Zhao","year":"2009","journal-title":"[World Chinese Journal of Digestology]"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-2-3","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2","author":"Altman","year":"2002","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-1","article-title":"Simpson's paradox and calculation of number needed to treat from meta-analysis","volume":"2","author":"Cates","year":"2002","journal-title":"BMC Medical Research Methodology"},{"issue":"32","key":"10.1002\/14651858.CD009034.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.11569\/wcjd.v17.i32.3365","article-title":"Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in Chinese patients: A meta-analysis. [Chinese]","volume":"17","author":"Chen","year":"2009","journal-title":"World Chinese Journal of Digestology"},{"issue":"8","key":"10.1002\/14651858.CD009034.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S1590-8658(01)80044-X","article-title":"Two new treatment regimens for Helicobacter pylori eradication: a randomised study","volume":"33","author":"Francesco","year":"2001","journal-title":"Digestive & Liver Disease"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s10620-006-9210-5","article-title":"Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys","volume":"51","author":"Martel","year":"2006","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7121","key":"10.1002\/14651858.CD009034.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"36B","DOI":"10.1155\/2003\/714124","article-title":"How can the current strategies for Helicobacter pylori eradication therapy be improved?","volume":"17 (Suppl B)","author":"Ford","year":"2003","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003840.pub5","article-title":"Therapies for the eradication of Helicobacter pylori","author":"Forman","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009034.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"147","author":"Fuccio","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/ajg.2009.555","article-title":"Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children","volume":"104","author":"Gatta","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009034.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1523-5378.2007.00576.x","article-title":"Evolution of Helicobacter pylori therapy from a meta-analytical perspective","volume":"12","author":"Gisbert","year":"2007","journal-title":"Helicobacter"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0b013e3181c8a1a3","article-title":"Sequential therapy for Helicobacter pylori eradication. A critical review","volume":"44","author":"Gisbert","year":"2010","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"11-12","key":"10.1002\/14651858.CD009034.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2036.2011.04887.x","article-title":"Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough","volume":"34","author":"Gisbert","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CEG.S25419","article-title":"Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori","volume":"5","author":"Gisbert","year":"2012","journal-title":"Clinical and Experimental Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.gastrohep.2013.01.011","article-title":"[III Spanish Consensus Conference on Helicobacter pylori infection]","volume":"36","author":"Gisbert","year":"2013","journal-title":"Gastroenterologia y Hepatologia"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-147-6-200709180-00022","article-title":"Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy","volume":"147","author":"Graham","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200868060-00001","article-title":"Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond","volume":"68","author":"Graham","year":"2008","journal-title":"Drugs"},{"issue":"7","key":"10.1002\/14651858.CD009034.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2036.2011.04944.x","article-title":"Letter: the ethics of using inferior regimens in H. pylori randomised trials","volume":"35","author":"Graham","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: A review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspectives in Clinical Research"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0092|cit92","volume-title":"Clinical Epidemiology: How to Do Clinical Practice Research","author":"Haynes","year":"2006"},{"issue":"44","key":"10.1002\/14651858.CD009034.pub2-BIB0093|cit93","first-page":"3500","article-title":"Ten-day sequential therapy for Helicobacter pylori eradication in children: a systematic review of randomized controlled trials","volume":"93","author":"He","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"10.1002\/14651858.CD009034.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD009034.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0096|cit96","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from cochrane.handbook.org"},{"issue":"7211","key":"10.1002\/14651858.CD009034.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2036.2012.05229.x","article-title":"Meta-analysis: sequential therapy for Helicobacter pylori eradication in children","volume":"36","author":"Horvath","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD009034.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1155\/2004\/326767","article-title":"Canadian Helicobacter Study Group Consensus Conference: update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection","volume":"18","author":"Hunt","year":"2004","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD009034.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","article-title":"Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment","volume":"148","author":"Hornung","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2036.2001.00974.x","article-title":"A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor\/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole","volume":"15","author":"Janssen","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD009034.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.1999.00542.x","article-title":"Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis","volume":"13","author":"Laheij","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD009034.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3748\/wjg.v10.i7.991","article-title":"Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers","volume":"10","author":"Lai","year":"2004","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1111\/j.1572-0241.2000.03349.x","article-title":"Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials","volume":"95","author":"Laine","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hel.12034","article-title":"Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study","volume":"18","author":"Lim","year":"2013","journal-title":"Helicobacter"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","article-title":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report","volume":"41","author":"Malfertheiner","year":"1997","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD009034.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection--the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1472-8206.2005.00340.x","article-title":"Eradication of Helicobacter pylori: recent advances in treatment","volume":"19","author":"McLoughlin","year":"2005","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD009034.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1S","key":"10.1002\/14651858.CD009034.pub2-BIB0113|cit113","first-page":"A64","article-title":"Sequential and concomitant treatments in H. pylori eradication: a network meta-analysis","volume":"2","author":"AG","year":"2014","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-2-2","article-title":"Pooling data for number needed to treat: no problems for apples","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Medical Research Methodology"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.36.6.845","article-title":"High Helicobacter pylori numbers are associated with low eradication rate after triple therapy","volume":"36","author":"Moshkowitz","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD009034.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/08989620500440287","article-title":"Rating methodological quality: toward improved assessment and investigation","volume":"12","author":"Moyer","year":"2005","journal-title":"Accountability in Research"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-8579(01)00456-3","article-title":"Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy","volume":"19","author":"Murakami","year":"2002","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"9","key":"10.1002\/14651858.CD009034.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: Prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"issue":"11","key":"10.1002\/14651858.CD009034.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/gut.2007.132514","article-title":"Helicobacter pylori and antibiotic resistance","volume":"56","author":"M\u00e9graud","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD009034.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"M\u00e9graud","year":"2007","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"M\u00e9graud","year":"2013","journal-title":"Gut"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"M1053","DOI":"10.1016\/S0016-5085(09)61556-0","article-title":"The 10-day sequential therapy for Helicobacter pylori eradication in Korea: less effective than expected","volume":"136","author":"Park","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD009034.pub2-BIB0123|cit123","first-page":"146","article-title":"Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection","volume":"30","author":"Perri","year":"1998","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0124|cit124","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD009034.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2036.2004.02029.x","article-title":"Seven-day therapy for Helicobacter pylori in the United States","volume":"20","author":"Vakil","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD009034.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gtc.2006.03.004","article-title":"Helicobacter pylori diagnosis and management","volume":"35","author":"Vilaichone","year":"2006","journal-title":"Gastroenterology Clinics of North America"},{"issue":"11","key":"10.1002\/14651858.CD009034.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1365-2036.2000.00863.x","article-title":"Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa","volume":"14","author":"Wong","year":"2000","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD009034.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2036.2000.00766.x","article-title":"A new highly effective short-term therapy schedule for Helicobacter pylori eradication","volume":"14","author":"Zullo","year":"2000","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9592","key":"10.1002\/14651858.CD009034.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(07)61455-X","article-title":"Sequential regimes for Helicobacter pylori eradication","volume":"370","author":"Moayyedi","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009034.pub2-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009034","article-title":"Sequential versus standard triple therapy for Helicobacter pylori eradication","author":"Nyssen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009034.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2710.2008.00969.x","article-title":"Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis","volume":"34","author":"Tong","year":"2009","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD009034.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regiment for Helicobacter pylori eradication: a pooled data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009034.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:15:59Z","timestamp":1718669759000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009034.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":132,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009034.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}